Morgan Stanley lends Werner and partners $150M for Pfizer HQ buy
Morgan Stanley is providing David Werner and his partners $150 million to finance their purchase of Pfizer’s headquarters in...
pfizer
The Latest
Here is how Pfizer’s sale-leaseback stacks up to other big deals
In 2016, Pfizer embarked on a daunting task: a search for both the buyer of its longtime two-building headquarters...
David Werner buying Pfizer’s Midtown HQ for $360M
UPDATED, 2:03 p.m., April 10: As it finalized its new lease at a proposed Hudson Yards skyscraper, Pfizer struck...
Ethnic tensions flare up over Rabsky’s plans for the Pfizer site
UPDATED, Oct. 10, 10:22 a.m.: The dispute over the Rabsky Group’s Pfizer development site in Williamsburg is turning into...
City Planning signs off on rezoning of Rabsky’s Pfizer sites
The City Planning Commission on Tuesday signed off on rezoning a group of Brooklyn properties — known as the...
Pfizer doesn’t want to waste time in signing huge lease deal with Tishman Speyer
Pfizer is aiming to ink a lease at Tishman Speyer’s Spiral tower by early 2018. The pharmaceutical giant plans...
Pfizer to move HQ to Tishman Speyer’s Spiral
After months of shopping, Pfizer will move its headquarters from Midtown to Hudson Yards, where it plans to anchor...
Does the proposed Midtown East rezoning incentivize Pfizer to skip town?
The density boost that the Pfizer headquarters will automatically get under the Midtown East rezoning means that the pharmaceutical...
Plans filed for “upscale religious housing” at former Pfizer site
UPDATED: Wednesday, March 29 at 12:31 p.m.: Developer Abraham Brach and Parkview Management plan to build a mixed-use apartment...
Pfizer sells last piece of its Broadway Triangle site for $28M
Pfizer sold the last remaining piece of its development site at Brooklyn’s Broadway Triangle. Developer Abraham Brach paid $27.5...